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Background: Mechanical ventilation (MV) is imperative in many forms of acute respiratory failure (ARF) in COPD
patients. Previous studies have shown the difficulty to identify parameters predicting the outcome of COPD
patients treated by invasive MV. Our hypothesis was that a non specialized score as the activities daily living (ADL)
score may help to predict the outcome of these patients.
Methods: We studied the outcome of 25 COPD patients admitted to the intensive care unit for ARF requiring
invasive MV. The patients were divided into those weaning success (group A n = 17, 68%) or failure (group B n = 8,
32%). We investigated the correlation between the ADL score and the outcome and mortality.
Results: The ADL score was higher in group A (5.1 ±1.1 vs 3.7 ± 0.7 in group B, p < 0.01). Weaning was achieved in
76.5% of the cases with an ADL score ≥ 4 and in 23.5% of the cases with an ADL score < 4 (p < 0.05). Pulmonary
function test, arterial blood gases collected during period of clinical stability and at admission and nutritional status
were similar in both groups. The mortality, at six months, was 36%. The ADL score was a significant predictor of
6-month mortality (80 with an ADL score <4, 20 with an ADL score ≥4, p < 0.01).
Conclusion: Our pilot study demonstrates that the ADL score is predictive of weaning success and mortality at
6 months, suggesting that the assessment of daily activities should be an important component of ARF
management in COPD patients.
Keywords: Chronic obstructive pulmonary disease, Acute respiratory failure, Mechanical ventilation weaning,
Mortality, Activities of Daily Living scoreBackground
The natural course of chronic obstructive pulmonary
disease is characterized by recurrent episodes of respira-
tory failure sometimes requiring mechanical ventilation
(MV). The use of non invasive ventilation (NIV) has
dramatically reduced the need of endotracheal intub-
ation (EI) [1], but EI remains required in case of failure
of NIV or initially life-threatening acute respiratory fail-
ure (ARF). The prognosis of ARF in chronic obstructive
pulmonary disease (COPD) patients requiring EI for MV* Correspondence: k.langlet@orange.fr
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reproduction in any medium, provided the oris poor with a one-year mortality ranging from 30 to
50 [2], representing a difficult challenge for the clini-
cians. Several studies have shown the difficulty to iden-
tify clinical and functional parameters predicting the
outcome of these COPD patients treated by invasive
MV [3,4]. However, these studies have been conducted
in 1980s-1990s, when NIV was not commonly used
in acute exacerbation of chronic pulmonary disease
(AE-COPD). Since NIV is nowadays largely used as first
line treatment in severe AE-COPD and also in ARF
whatever the cause, the severity of patients requiring in-
vasive MV has increased [5]. In this study, we carefully
analyzed the current characteristics of COPD patients
requiring invasive MV for ARF and the correlations
with weaning success or failure.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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activities daily living (ADL) score may help to predict
the outcome of these patients. To test this hypothesis,
we conducted a pilot study to investigate the correlation
between the ADL score, clinical and pulmonary function
parameters, and the outcome and mortality of COPD
patients requiring invasive ventilation.
Methods
Study design
All COPD patients with ARF admitted to the intensive
care unit (ICU) of the Saint Philibert Hospital in France
were considered for inclusion. The criteria of inclusion
was ARF requiring EI for MV in a patient with a diagno-
sis of COPD based on at least one pulmonary function
test (PFT) performed during a phase of clinical stability
before AE-COPD. The diagnosis of COPD was estab-
lished on the basis of the Global Initiative for chronic
Obstructive Lung disease (GOLD) consensus statement
as a ratio of forced expiratory volume in one second
over forced vital capacity (FEV1/FVC) of less than 0.7
after the administration of 200 μg of salbutamol [6].
Exclusion criteria were neuromuscular disease, re-
strictive pulmonary disorder defined by PFT showing a
predicted total lung capacity of less than 80%, cancer,
patients without PFT values at stable state and patients
improving with only NIV.
All the patients were ventilated using conventional
respirators in the assist control (A/C) mode. The wean-
ing procedure was standardized. Weaning trials were
performed switching the ventilator to the pressure sup-
port ventilation mode, with a peak inspiratory pressure
(PIP) between 12 to 20 cm H2O to maintain an expira-
tory tidal volume (Vt) about 5 ml.kg -1, a respiratory rate
between 20 to 30/min and an arterial oxygen saturation
(SaO2) > 93%. As soon as PIP reached 12 cm H2O with a
good tolerance, a test of spontaneous ventilation with a
T-tube was performed. In case of failure, the test was
repeated every day. If the patient was able to breathe for
120 minutes without mechanical support, extubation
was performed.
Patients were divided into two separate groups for data
analysis, those weaned from MV (Group A), and those
not weaned (Group B). Weaning success was defined as
breathing autonomy during at least 48 h after extubation
with SpO2 > 90and the absence of signs of muscular
weakness [7]. Weaning failure was defined as death while
on MV or failure to be disconnected from the respirator
despite repeated weaning trials during at least 30 days [8].
Mechanical ventilation
NIV was used before intubation in 20 patients (80%).
Immediate EI for MV was performed in 5 patients
(20%) because of comatose (n = 4) or near fatal acuterespiratory failure with tachypnea and paradoxal
breathing (n = 1). When used, initial NIV was per-
formed in pulmonary medicine unit (n = 2, 10%),
emergency unit (n = 12, 60%) or ICU (n = 6, 30%). NIV
was performed using conventional respirators: Legen-
dairW (Airox), EvitaW (Dräger) or EngströmW (General
Electric) in the PIP + positive expiratory pressure (PEP)
mode with a naso-buccal mask. The failure of the non in-
vasive approach was related to exhaustion (n = 15, 75%),
occurrence or persistence of coma (n = 5, 25%), or in-
tolerance of NIV with major anxiety, agitation, or vomitis
(n = 3, 15%). In invasive approach, all patients were venti-
lated with EvitaW or EngströmW in the A/C mode. The
median length of invasive MV was 9 days (2–90) in
Group A, and 20 days (8–42) in Group B (p = 0.04). In
group A, a tracheotomy was performed in 3 patients.
Data collection
At inclusion, demographic data (age, sex, weight, height,
body mass index), nutritional risk index (NRI), albumin,
prealbumin, arterial blood gases, echocardiographic
results for left ventricular ejection fraction (LVEF) and
systolic pulmonary arterial pressure (PAPs) and the sim-
plified acute physiology score (SAPSII) were systematic-
ally recorded. Daily activity was assessed at admission
using the activities of daily living score (ADL) [7]. This
score is based on 6 criteria: 1) bathing with sponge, bath,
or shower, 2) dressing, 3) toilet use, 4) transferring (in
and out of bed or chair), 5) urine and bowel continence,
6) eating. The index ranks adequacy of performance in
these six functions with a yes/no score for each of the
six functions. A score of 6 indicates full function, 4 indi-
cates moderate impairment, and 2 or less indicates se-
vere functional impairment.
Initial use of NIV, cause of acute respiratory failure
(acute bronchitis, pneumonia, pulmonary embolism. . .),
Logistic Organ Dysfunction System (LODS) score and
all medical events occurring during hospitalization (toxic
shock, nosocomial infections, respect of nutritional tar-
get, curare using) were recorded. Weaning success or
failure and its term were noted.
The PFT and arterial blood gases obtained from a
phase of clinical stability before ARF were also recorded.
The study was approved by the Institutional Review
Board at the University Hospital of Reims (France), and
patient consent was waived.
Two authors (K Langlet and G Deslee) had full access
to all the data in the study and take responsibility for the
integrity of the data and the accuracy of the data ana-
lysis, including and especially any adverse effects.
Data analysis
The Kaplan-Meier method was used to analyse survival.
Statistical analysis to compare the difference between
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using Fischer Test, Kruskal-Wallis test, Spearman and Tau
Kendall test. This statistical analysis was retrospective.
A p-value of less 0.05 was considered significant.
Results
Patients
Between January 2008 to January 2010, 53 patients were
admitted in the intensive care unit (ICU) of the Saint
Philibert Hospital in France for ARF. Seven patients
(13.2%) improved with NIV and were not intubated.
Among the 46 patients requiring invasive MV, 9 (19.5%)
were excluded because of a restrictive pulmonary dis-
order related to obesity (n = 7, 78%) or tuberculosis se-
quelae (n = 2, 22%). Twelve patients (26%) were
excluded because of absence of PFT performed before
admission in ICU, then the diagnosis of COPD before
respiratory failure was not possible to establish. There-
fore, 25 patients were considered in the data analysis
(Figure 1). The characteristics of the patients included
are presented in Table 1. Failure to wean occurs in 32%
of patients (n = 8). The median age was 68 years (49–
81), there were 24% of females and 76% of males. Me-
dian SAPSII was 39 (22–79). Median ADL score was 3.7.
The severity of COPD according to GOLD was a fol-
lows: 46% GOLD IV (very severe), 16% GOLD III (se-
vere), 38% GOLD II (moderate). Median ratio PaO2/
FiO2 was 220 (22–250). Median pH at admission was
7.25 (7.07-7.39), median PCO2 was 75 mmHg (50–114).
The mains causes of respiratory failure were acute
bronchitis (n = 12, 48%), pneumonia (n = 9, 36%) and
pulmonary embolism (n = 2, 8%). Median BMI was
25 kg /m2 (18–37). Median NRI was 82.9 (66–102).January 2008 to Janu
53 patients referred to ICU
46 patients intubated 
25 COPD patients intubat
Figure 1 Studied and excluded patients.According to these results, 92% of the patients were
undernourished and 56% had malnutrition.
Prognosis factors
Next, we investigated the relationships between demo-
graphic characteristics, PFT, arterial blood gas, causes of
respiratory failure, nutritional status, corticosteroids
treatments, cardiac assessment and the probability for
the patient to be weaned (Group A) or not (Group B)
from MV (Table 1). In this study, the only variable which
was correlated with weaning success was the ADL score
(respectively 5.1 ±1.1 versus 3.7 ± 0.7 p < 0.01)
(Figure 2A). Interestingly, weaning was achieved in
76.5% of the cases with an ADL score ≥ 4 and in 23.5%
of the cases with an ADL score < 4 (p < 0.05) (Figure 2B).
Next, we investigated the relationships between the
occurrence of nosocomial infections, failure of organs,
curare use and the probability for the patient to be
weaned. 11.8% of patients in group A were treated by
curare, 12.5% in group B, the difference was no signifi-
cant. The rate of nosocomial infection was significantly
higher in the group B (p < 0.01), whereas organs failure
and the use of curare did not reach statistical signifi-
cance. Nosocomial infections were pneumonia (n = 5,
50%), urinary infections (n = 3, 30%) and bacteraemia
(n = 2, 20%). The most frequently identified pathogens
were Pseudomonas aeruginosa (n = 4, 40%), Escherichia
coli (n = 3, 30%), Staphylococcus aureus and Staphylococ-
cus epidermidis (n = 2, 20%).
Long-term outcome
Informations regarding survival and the ADL score were
collected by phone six months later. Survival data in theary 2010 
 for AE-COPD. 
7 patients:  
Improvement with only NIV 
21 patients excluded: 
        - n= 9: restrictive pulmonary disorder. 
        - n= 12: COPD diagnosis not proved 
ed for AE-COPD 
Table 1 Comparison of simple parameters recorded before endo-tracheal intubation in weaned and not weaned
groups
Total (n = 25) Group A (n = 17) a Group B (n = 8) a P
Weaned not weaned
General characteristics
Age,yr b 68 [49–81] 68 [49–81] 68.5 [51–77] 0.52
M/F 19/6 13/4 6/2 0.68
SAPS II
b 39 [22–79] 39 [28–79] 38.5 [22–69] 0.69
Pulmonary status during a phase of clinical stability
FEV1 l
b 0.66 [0.220-2.50] 0.710 [0.220-2.50] 0.630 [0.32-1.47] 0.60
FEV1predicted
b 30 [11–80] 31 [11–80] 26.5 [15–50] 0.33
PaO2 mmHg
b 69 [41–95] 69 [50–95] 69 [41–86] 0.52
PaCO2 mmHg
b 49 [30–91] 48 [30–91] 54 [40–61] 0.37
pH b 7.40 [7.28-7.50] 7.40 [7.33-7.50] 7.38 [7.28-7.45] 0.84
Arterial blood gases at admission
PaO2/FiO2
b 220 [22–250] 220 [22–250] 157 [120–250] 0,57
PaCO2 mmHg
b 75 [50–114] 74.5 [56–114] 76 [50–102] 0,46
pH b 7.25 [7.07-7.39] 7,29 [7.07-7.37] 7,24 [7.08-7.39] 0.49
Cardiac echography at admission
LVEF b 60 [30–70] 60 [40–70] 50 [30–65] 0.26
PAPs b 45 [25–80] 45 [25–65] 50 [30–80] 0.45
Cause of respiratory failure
Acute exacerbation a 12 (48%) 8 (47%) 4 (50%) 0.63
Pneumonia a 9 (36%) 5 (30%) 4 (50%) 0.37
Pulmonary embolism a 2 (8%) 2 (11.5%) 0 (0%) 0.43
Other a 2 (8%) 2 (11.5%) 0 (0%) 0.43
Nutritional status
BMI b 25 [18–37] 25 [19–36.7] 25 [18–37] 0.86
NRI b 82.9 [66–102] 82.8 [66–93] 80.4 [73–102] 0.73
Albumin b 27 [20–38] 27 [20–34] 27.5 [21–38] 0.49
Prealbumin b 195 [74–400] 215 [130–400] 164 [74–337] 0.50
Corticoïds a 3 (12%) 2 (11.8%) 1 (12.5%) 0.72
ADL score c 4.6 ± 1.1 5,1 ±1.1 3.7 ± 0.7 0.006
a data are expressed as numbers (%); b data are expressed as median [minimum – maximum] c: mean ± SD.
M male, F female.
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Figure 3. At six months, the overall rate of mortality
was 36%. All the patients of group B died within 42 days
after ICU admission with a median delay of 22 days (8–
42). No patient died after weaning during the
hospitalization in ICU. One patient was readmitted in
ICU within 6 months for AE-COPD and died during
this hospitalization. 41% of the surviving patients were
readmitted for AE-COPD in pulmonary medicine unit
within 6 months. 12% of the patients have been hospita-
lized in rehabilitation centre before being discharged at
home. 18% were treated by nocturnal non invasive ven-
tilation at home at 6 months. The median ADL score ofsurviving patient was performed at six months (5.1
versus 4.3, p <0.05).
The predictive factors of mortality at 6 months were
the ADL score at admission (ADL ≤ 4, p = 0.014) and
nosocomial infection (p = 0.008).
Discussion
This prospective observational long-term monocenter
study analysed the predictive factors of ventilator wean-
ing and mortality in a series of 25 COPD patients with
ARF requiring EI for mechanical ventilation. Our results
demonstrated that a low ADL score (≤4) at admission








































weaning and score ADL Percentage of weaning success
according to ADL score
*
Figure 2 A. Weaning and ADL score. B. Percentage of weaning success according to ADL score.
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clinical, functional or biological parameters at admission
associated with the risk of weaning failure or mortality.
In our study, the diagnosis and the severity of COPD
were very carefully investigated and were based on PFT
results obtained at stable state before admission in ICU,
allowing to exclude other causes of chronic respiratory
diseases than COPD. Moreover, the same type of treat-
ment, mechanical ventilation and respirator weaning
procedure were applied to all patients in this monocen-
ter study. Most of the patients (80%) had been treated
by NIV before intubation as currently recommended [9].
The intubation for MV was based on definite clinical
and blood gas criteria which were correlated with a
high rate of NIV failure (respiratory frequency >35/mn,
pH < 7.25 at admission [10], coma [11]). None of the
patients was weaned within the first 48 h, suggesting that
the indication of intubation was appropriate. The nutri-
tional status was very precarious with 92undernourishedGroup A weaned






Figure 3 Kaplan-Meier Survival curve of the weaned and not
weaned groups.and 56with malnutrition. The degree of denutrition is
more important in our series than in other studies pub-
lished before the use of NIV [2-4], which could be
related to the selection of more severe patients not
responding to NIV in our study.
The prognosis of patients with ARF requiring EI for
mechanical ventilation is poor. In this study, the mortal-
ity rate at 6 months is of 36%, which is in accordance
with previous series [2-4]. Of notes, almost all the
patients (8/9) are died not weaned. Several explanations
can be proposed to account for difficulties of weaning
and mortality: terminal stage of respiratory insufficiency,
impaired pulmonary function, muscular weakness,
hypercapnia [12-14]. However, the prediction of out-
come after invasive mechanical ventilation of COPD
patients remains a difficult challenge. The value of FEV1
as predictor of weaning difficulties has been investigated
in different studies with different results. Menzies and al
[3] showed a significant correlation between weaning
difficulties and mortality at one year and FEV1 impair-
ment, whereas other studies did not find any correlation
with FEV1 [15]. In our study, we did not find any correl-
ation between FEV1 or any clinical or functional data at
inclusion and the outcome COPD patients treated by
invasive MV. Menzies and al [3] showed that a model
involving eight parameters (fever, FEV1/FVC, age,
premorbid hypercapnia, hyperleukocytosis, number of
previous intubation, low-flow oxygen treatment, plasma
protein level) was able to predict outcome in 78of
AE-COPD treated by invasive mechanical ventilation.
We found an association between weaning failure and
nosocomial infection. However, it must be pointed out
that this does not imply a causal relationship. It can be
assumed that patients who fail to wean have an
increased duration of MV and require higher levels of
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may be a consequence of poor status at admission. In
this study, the occurrence of nosocomial infection asso-
ciated with failure organs led to stop active therapy. The
do-not-resuscitate decision was warranted by the reject
or the disability to perform a tracheotomy. Almost all
patients (8/9), who failed to wean died and no patient
has been stabilized by chronic intermittent ventilation.
The use of curare might be responsible of more fre-
quent failure of weaning, even if it is not statistically sig-
nificant in our study involving a limited number of
patients. The use of curare is more frequent when the
situation is more severe, leading to a potential bias as for
its association with the failure of weaning. Nevertheless,
toxicity of curare on neuromuscular function is known,
slowing the weaning, especially when they are used for a
long time.
In our study, the only parameter identified at admis-
sion as predictive factor of both weaning success and
long-term survival was the premorbid level of activity
assessed by the ADL score. An ADL score ≥ 4 was asso-
ciated with 76.5of weaning success, whereas an ADL < 4
was associated with only 23.5of weaning success. Inter-
estingly, a low ADL score (ADL < 4) was also a strong
predictor of mortality at 6 months. As suggested by
other studies, the premorbid level of activity is influ-
enced by many factors involving clinical and functional
parameters but also unmeasurable factors such as motiv-
ation, family support or other psychosocial factors
[3,16]. It must be pointed out that the ADL score inves-
tigated in this study is a very simple and easy-to-use
score in clinical practise. However, our study has several
limitations which do not permit to come to a definitive
conclusion regarding the interest of the ADL score in
clinical practise. The number of patients included in this
monocenter study is small and our results have to be
confirmed in additional larger multicenter studies.
Moreover, the rate of 23.5of weaning success in patients
with a low ADL score (<4) reported in this study is not
ethically acceptable to be used as a single parameter in
the decision to use or not EI in ARF of COPD patients
requiring invasive MV.Conclusion
Our prospective monocenter study involving 25 con-
secutive ARF in COPD patients requiring invasive MV
confirmed the difficulty to determine predictive factors
of success or failure of weaning and mortality. At admis-
sion, only the ADL score was predictive of weaning suc-
cess and mortality at 6 months. Our results suggest that
the assessment of daily activities should be an important
component of ARF management in COPD patients. This
work is a pilot study and further studies are needed toinvestigate the ADL score and other potentially more
accurate scores of daily activities in clinical practice.
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